Cellular bioenergetics after erythropoietin therapy in chronic renal failure.

After erythropoietin (rHuEPO) therapy, patients with chronic renal failure (CRF) do not improve peak O2 uptake (VO2 peak) as much as expected from the rise in hemoglobin concentration ([Hb]). In a companion study, we explain this phenomenon by the concurrent effects of fall in muscle blood flow afte...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Marrades, R M, Alonso, J, Roca, J, González de Suso, J M, Campistol, J M, Barberá, J A, Diaz, O, Torregrosa, J V, Masclans, J R, Rodríguez-Roisin, R, Wagner, P D
Format: Artigo
Idioma:Inglês
Publicat: 1996
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC507285/
https://ncbi.nlm.nih.gov/pubmed/8621800
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars